Trial Profile
Open-Label, Fixed-Sequence, Crossover Study To Estimate The Pharmacokinetic Interaction Between Multiple Dose Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 01 Feb 2011
Price :
$35
*
At a glance
- Drugs Fosamprenavir (Primary) ; Maraviroc (Primary) ; Ritonavir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 14 Jan 2011 Planned end date changed from 1 Dec 2010 to 1 Oct 2010 as reported by ClinicalTrials.gov.
- 14 Jan 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 28 Oct 2010 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.